Position in GSK
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$458,098
-$38,446 QoQ
Shares Held
8,739
-2.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#495
of 1,032 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IVC Wealth Advisors LLC holds $8,869,908 across 8 Drug Manufacturers - General names. GSK ranks #5 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
21,139 | $2,716,361 | |
| 2 | JNJ |
Johnson & Johnson
|
10,167 | $2,582,112 | |
| 3 | LLY |
ELI LILLY & Co
|
1,341 | $1,608,435 | |
| 4 | AMGN |
Amgen Inc
|
1,547 | $560,199 | |
| 5 | GSK |
GSK plc
This page
|
8,739 | $458,098 | |
| 6 | ABBV |
AbbVie Inc.
|
1,767 | $444,647 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,201 | $299,681 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,586 | $200,375 |
All Filings in GSK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $458,098 | 8,739 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $496,544 | 8,997 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $425,422 | 8,675 | Shares | Sole | 2026-01-16 | |
| No filing history on record for this holder in this stock. | ||||||